Unknown NA INTERVENTIONAL NCT00247299

Evaluation and Optimization of the Technical and Clinical Performance of the Lumenis ONE Platform

Sponsor: Lumenis Be Ltd.

Conditions Port Wine Stain Telangiectases

Interventions IPL Quantum Product manufactured by Luminis Ltd.

Updated 5 times since 2017 Last updated: Oct 30, 2005 Started: May 31, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Port Wine Stain and Telangiectases and is currently ongoing. Lumenis Be Ltd. leads this study, which shows 5 recorded versions since 2005 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Nov 2022 — Jul 2024 [monthly]

Unknown Status NA
Jan 2021 — Nov 2022 [monthly]

Unknown Status NA
Jan 2017 — Jan 2021 [monthly]

Unknown Status NA

First recorded

May 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Lumenis Be Ltd.
Rambam Health Care Campus

Data source: Rambam Health Care Campus

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Haifa, Israel